Shortly after receiving approval from the U.S. Food & Drug Administration, Abbott selected St. Luke’s Heart & Vascular Center as one of the first sites in the nation – and the only site in the Lehigh Valley region – to use the world's first dissolving heart stent to treat Coronary Artery Disease (CAD), which affects 15 million people in the United States.
Abbott joins a long list of medical-device companies in selecting St. Luke’s Heart & Vascular Center to pioneer it's product.
The Absorb dissolving stent treats coronary artery disease like a metallic stent, but then disappears after the artery is healed, leaving no metal behind to restrict natural vessel motion.
How It Works
St. Luke’s Heart & Vascular Center stands among the first healthcare providers in the country to pioneer:
- Transcatheter aortic valve replacement (TAVR) – only available in the Lehigh Valley at St. Luke’s.
- Mitra Clip percutaneous mitral valve repair – only available in the Lehigh Valley at St. Luke’s.
- The world's smallest Pacemaker, The Micra Pacemaker – only available in the Lehigh Valley at St. Luke’s.
- And now, Abbott's dissolving stent